<?xml version="1.0" encoding="utf-8" standalone="yes"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Earnings Reports on FinanClub</title>
    <link>https://finan.club/tags/earnings-reports/</link>
    <description>Recent content in Earnings Reports on FinanClub</description>
    <generator>Hugo -- gohugo.io</generator>
    <language>en-us</language>
    <lastBuildDate>Tue, 23 Jan 2024 09:06:23 +0000</lastBuildDate><atom:link href="https://finan.club/tags/earnings-reports/index.xml" rel="self" type="application/rss+xml" />
    <item>
      <title>JNJ</title>
      <link>https://finan.club/us/jnj/</link>
      <pubDate>Tue, 23 Jan 2024 09:06:23 +0000</pubDate>
      
      <guid>https://finan.club/us/jnj/</guid>
      <description>score:72
Chances: Johnson &amp;amp; Johnson&amp;rsquo;s spin-off of its consumer health division may lead to increased focus and growth in its pharmaceutical and medtech segments The addition of serious warnings for cancer therapies may lead to increased caution and monitoring for potential adverse effects, which could impact the stock&amp;rsquo;s performance.</description>
    </item>
    
  </channel>
</rss>
